CSF2 and COVID-19: Alternatively, PBMCs may be another in vivo source for pGM-CSF production in piglets which may mirror the scenario of COVID-19 patients as increased percentages of GM-CSF-producing leukocytes have been found in blood of COVID-19 patients (43).